Sitagliptin and Metformin Hydrochloride
NDC 70710-2036, sitagliptin and metformin hydrochloride, tablet, film coated, extended release, from Zydus Pharmaceuticals USA Inc..
- Product NDC
- 70710-2036
- Status
- Listed
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA AUTHORIZED GENERIC
- Application
- NDA216778
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70710-2036 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SITAGLIPTIN50 mg/1
- METFORMIN HYDROCHLORIDE500 mg/1
Pharmacologic classes
Biguanide [EPC]; Biguanides [CS]; Dipeptidyl Peptidase 4 Inhibitor [EPC]; Dipeptidyl Peptidase 4 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70710-2036-6 | 70710203606 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (70710-2036-6) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/d3a728a0-decb-4340-8ee4-c5e27c13eb19
Use it
Look up 70710-2036 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70710-2036 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70710-2036. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.